Browsing by Author "Guitera, Pascale"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Deep Learning for Basal Cell Carcinoma Detection for Reflectance Confocal Microscopy
    (2022) Campanella, Gabriele; Navarrete-Dechent, Cristian; Liopyris, Konstantinos; Monnier, Jilliana; Aleissa, Saud; Minhas, Brahmteg; Scope, Alon; Longo, Caterina; Guitera, Pascale; Pellacani, Giovanni; Kose, Kivanc; Halpern, Allan C.; Fuchs, Thomas J.; Jain, Manu
    Basal cell carcinoma (BCC) is the most common skin cancer, with over 2 million cases diagnosed annually in the UnitedStates. Conventionally, BCC is diagnosed by naked eye examination and dermoscopy. Suspicious lesions are either removed or biopsied for histopathological confirmation, thus lowering the specificity of noninvasive BCC diagnosis. Recently, reflectance confocal microscopy, a noninvasive diagnostic technique that can image skin lesions at cellular level resolution, has shown to improve specificity in BCC diagnosis and reduced the number needed to biopsy by 2-3 times. In this study, we developed and evaluated a deep learning-based artificial intelligence model to automatically detect BCC in reflectance confocal microscopy images. The proposed model achieved an area under the curve for the receiver operator characteristic curve of 89.7%(stack level) and 88.3%(lesion level), a performance on par with that of reflectance confocal microscopy experts. Furthermore, themodel achieved an area under the curve of 86.1% on a held-out test set from international collaborators, demonstrating the reproducibility and generalizability of the proposed automated diagnostic approach. These results provide a clear indication that the clinical deployment of decision support systems for the detection of BCC in reflectance confocal microscopy images has the potential for optimizing the evaluation and diagnosis of patients with skin cancer.
  • Thumbnail Image
    Item
    Position statement of the EADV Artificial Intelligence (AI) Task Force on AI-assisted smartphone apps and web-based services for skin disease
    (2024) Sangers, Tobias E.; Kittler, Harald; Blum, Andreas; Braun, Ralph P.; Barata, Catarina; Cartocci, Alessandra; Combalia, Marc; Esdaile, Ben; Guitera, Pascale; Haenssle, Holger A.; Kvorning, Niels; Lallas, Aimilios; Navarrete-Dechent, Cristian; Navarini, Alexander A.; Podlipnik, Sebastian; Rotemberg, Veronica; Soyer, H. Peter; Tognetti, Linda; Tschandl, Philipp; Malvehy, Josep
    Background: As the use of smartphones continues to surge globally, mobile applications (apps) have become a powerful tool for healthcare engagement. Prominent among these are dermatology apps powered by Artificial Intelligence (AI), which provide immediate diagnostic guidance and educational resources for skin diseases, including skin cancer.Objective: This article, authored by the EADV AI Task Force, seeks to offer insights and recommendations for the present and future deployment of AI-assisted smartphone applications (apps) and web-based services for skin diseases with emphasis on skin cancer detection.Methods: An initial position statement was drafted on a comprehensive literature review, which was subsequently refined through two rounds of digital discussions and meticulous feedback by the EADV AI Task Force, ensuring its accuracy, clarity and relevance.Results: Eight key considerations were identified, including risks associated with inaccuracy and improper user education, a decline in professional skills, the influence of non-medical commercial interests, data security, direct and indirect costs, regulatory approval and the necessity of multidisciplinary implementation. Following these considerations, three main recommendations were formulated: (1) to ensure user trust, app developers should prioritize transparency in data quality, accuracy, intended use, privacy and costs; (2) Apps and web-based services should ensure a uniform user experience for diverse groups of patients; (3) European authorities should adopt a rigorous and consistent regulatory framework for dermatology apps to ensure their safety and accuracy for users.Conclusions: The utilisation of AI-assisted smartphone apps and web-based services in diagnosing and treating skin diseases has the potential to greatly benefit patients in their dermatology journeys. By prioritising innovation, fostering collaboration and implementing effective regulations, we can ensure the successful integration of these apps into clinical practice.